Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China flag China · Delayed Price · Currency is CNY
12.05
-0.38 (-3.06%)
Apr 9, 2026, 3:04 PM CST

SHE:301211 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
5,0325,1036,1236,2648,3169,026
Market Cap Growth
-2.50%-16.66%-2.25%-24.68%-7.87%-
Enterprise Value
3,4803,5364,5114,4166,4278,614
Last Close Price
12.0512.2214.4614.3818.8620.20
PE Ratio
150.63146.1866.8835.5766.1174.20
PS Ratio
11.1011.2613.739.4516.1516.70
PB Ratio
2.212.252.652.663.654.06
P/TBV Ratio
2.282.312.732.743.774.19
P/FCF Ratio
----47.5687.71
P/OCF Ratio
666.43675.8363.7345.7033.1672.80
EV/Sales Ratio
7.687.8010.126.6612.4815.93
EV/EBITDA Ratio
67.3471.2984.0326.6667.1462.68
EV/EBIT Ratio
-477.42152.2030.3785.2972.96
EV/FCF Ratio
-77.72---36.7683.70
Debt / Equity Ratio
0.000.000.000.000.00-
Debt / EBITDA Ratio
0.060.060.090.040.08-
Debt / FCF Ratio
----0.04-
Net Debt / Equity Ratio
-0.68-0.68-0.71-0.77-0.86-0.84
Net Debt / EBITDA Ratio
-31.29-31.29-30.39-10.97-20.42-13.53
Net Debt / FCF Ratio
34.6634.6623.8736.73-11.18-18.07
Asset Turnover
0.190.190.180.260.210.35
Inventory Turnover
2.712.712.042.763.623.20
Quick Ratio
14.4114.4110.4410.8610.0119.65
Current Ratio
15.6415.6411.4011.9810.6620.67
Return on Equity (ROE)
1.52%1.52%3.92%7.60%5.59%8.32%
Return on Assets (ROA)
0.19%0.19%0.74%3.60%1.95%4.71%
Return on Invested Capital (ROIC)
0.89%0.90%4.44%29.32%18.58%28.75%
Return on Capital Employed (ROCE)
0.30%0.30%1.30%6.10%3.30%5.30%
Earnings Yield
0.69%0.68%1.49%2.81%1.51%1.35%
FCF Yield
-0.89%-0.88%-1.12%-0.79%2.10%1.14%
Dividend Yield
1.39%-1.19%2.30%1.22%0.85%
Payout Ratio
206.24%206.24%151.00%54.51%57.24%-
Buyback Yield / Dilution
-4.87%-5.20%0.91%-0.97%-33.19%1.01%
Total Shareholder Return
-3.46%-5.20%2.10%1.33%-31.97%1.86%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.